EP1203580A1 — Quickly disintegrating solid preparations
Assigned to Takeda Pharmaceutical Co Ltd · Expires 2002-05-08 · 24y expired
What this patent protects
Quickly disintegrating solid preparations which contain: a) an active ingredient; b) D-mannitol having an average particle size of 30 µm to 300 µm; c) a disintegrating agent; and d) celluloses.
USPTO Abstract
Quickly disintegrating solid preparations which contain: a) an active ingredient; b) D-mannitol having an average particle size of 30 µm to 300 µm; c) a disintegrating agent; and d) celluloses.
Drugs covered by this patent
- Prilosec (omeprazole) · AstraZeneca (originally Astra AB)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.